Analysts Set Karyopharm Therapeutics Inc. (NASDAQ:KPTI) PT at $45.60
Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) have earned a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock […]
Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) have earned a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock […]
